Pharma & drug development · Reference
What is a dose–response curve?
A dose–response curve describes how the magnitude of a drug’s effect changes as the dose increases. It is a foundational pharmacology concept that underpins the ideas of efficacy, potency and EC50 — a research tool, not dosing advice.
How the curve is built
A dose–response curve plots the size of a drug’s effect against the dose or concentration that produces it. When dose is shown on a logarithmic scale, the relationship usually takes a characteristic sigmoidal, or S-shaped, form: little effect at very low doses, a steep rise across an intermediate range, and a plateau where increasing the dose adds no further effect. This shape is a central tool of pharmacodynamics, giving a visual summary of how a drug’s effect scales with exposure. It is a conceptual and analytical device used in research and education, not a chart for setting any individual’s dose.
EC50, efficacy and potency
The curve yields several defining measures. EC50 (or ED50) is the concentration or dose producing half of the maximum effect — a standard index of potency, since a drug that reaches half-maximal effect at a lower dose is more potent. The height of the plateau represents efficacy: the maximum effect the drug can produce, however large the dose. Crucially, potency and efficacy are independent — a very potent drug may have modest maximum efficacy, and vice versa. The curve also distinguishes a full agonist, which reaches the maximal response, from a partial agonist, which plateaus lower. These are educational descriptors of drug behaviour, not dosing guidance.
Why the curve matters
Dose–response analysis is foundational across pharmacology and toxicology. The same logic that describes a beneficial effect also describes a toxic one, and comparing the two underlies safety concepts such as the therapeutic index. During drug development, dose–response data help characterise how a candidate behaves and inform how studies are designed.
The curve is best understood as a way of expressing a quantitative relationship between exposure and effect for research purposes. It describes how drugs behave in principle and is not a tool for determining how any person should use a medicine.
Key facts
At a glance
- Definition: Effect plotted against dose of a drug
- Shape: Usually sigmoidal on a log-dose scale
- EC50/ED50: Dose giving half the maximum effect
- Potency: Lower EC50 means more potent
- Efficacy: Height of the plateau — maximum effect
- Independent: Potency and efficacy are separate properties
Common questions
FAQ
What is a dose–response curve?+
A dose–response curve shows how the size of a drug’s effect changes as the dose increases, usually forming an S-shaped curve on a log-dose scale. It is a foundational pharmacology concept used in research, not a tool for setting an individual’s dose.
What is EC50 on a dose–response curve?+
EC50 is the concentration of a drug that produces half of its maximum effect. It is a standard measure of potency: a drug with a lower EC50 reaches half-maximal effect at a smaller dose and is therefore more potent. It is an educational descriptor, not dosing guidance.
What is the difference between efficacy and potency?+
Efficacy is the maximum effect a drug can produce — the height of the curve’s plateau — while potency is the amount of drug needed to produce a given effect, indexed by EC50. They are independent: a potent drug is not necessarily more efficacious.
The step most authors miss
Doing CRediT right? Don’t stop at the statement.
A CRediT statement credits you inside one paper. The recognition CRediT was built for happens when those roles are tied to you, persistently. Sign in with your ORCID — free — and claim your CRediT contributions on casrai.org, the home of the standard. They become a verified, portable part of your identity, not a line that disappears into one PDF.
Free: claim your contributions, then export a journal-ready CRediT statement, schema.org structured data, JATS XML, CSV or BibTeX — and preview your public profile. A membership publishes that profile publicly and verifies the journals you serve.
